Policy Notices

• Guidance for Surgeon Effort Level on AHRQ Individual Mentored K Awards
  (NOT-HS-22-018)
  Agency for Healthcare Research and Quality
  

• Notice to Extend PA-17-232
  (NOT-HS-22-019)
  Agency for Healthcare Research and Quality
  

General Notices

• Pre-Application Webinar for NCI's Technologies and Informatics Tools for Cancer Metabolomics NOSI (NOT-CA-22-083)
  (NOT-CA-22-095)
  National Cancer Institute
  

• Notice of Pre-Application Webinar for NOT-CA-21-100 "Administrative Supplements to Participate in the NCI Early-stage Surgeon Scientist Program (ESSP)"
  (NOT-CA-22-100)
  National Cancer Institute
  

• Notice of Pre-Application Webinar for Precision Approaches in Radiation Synthetic Combinations (PAIRS): PAR-22-198 (R01 Clinical Trial Optional), PAR-22-199 (R21 Clinical Trial Optional)
  (NOT-CA-22-109)
  National Cancer Institute
  

• Notice Announcing Frequently Asked Questions (FAQs) for the Maternal-Fetal Medicine Units Network and Neonatal Research Network Funding Opportunity Announcements
  (NOT-HD-22-025)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Additional FOAs for NHLBI participation in NOT-OD-21-100 "Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health"
  (NOT-HL-22-028)
  National Heart, Lung, and Blood Institute
  

• The National Institutes of Health (NIH) Sexual & Gender Minority Research Office (SGMRO) Announces Regional Workshop on Sexual and Gender Minority (SGM)-Related Health Research
  (NOT-OD-22-160)
  Office of the Director, NIH
  

Notice of Changes to Funding Opportunities

• Notice to Extend the Application Due Date for RFA-FD-22-020 - "OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Optional"
  (NOT-FD-22-015)
  Food and Drug Administration
  

• Notice of Change of Key Dates for PAR-19-380: Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25)
  (NOT-HG-22-028)
  National Human Genome Research Institute
  

• Notice of Participation of NIMHD in NOT-OD-22-126, Notice of Special Interest (NOSI): Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship Awards to Support Training in Research Related to Down Syndrome as Part of the INCLUDE Project
  (NOT-MD-22-020)
  National Institute on Minority Health and Health Disparities
  

• Notice to Discontinue NINDS Participation in "Stephen I. Katz Early Stage Investigator Research Project Grant" Funding Opportunity Announcements PAR-21-038 and PAR-21-039
  (NOT-NS-23-017)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Change in Required Registrations for PA-22-179 "PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)"
  (NOT-OD-22-161)
  Office of the Director, NIH
  

• Notice of Change in Required Registrations for PA-22-177 "PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)"
  (NOT-OD-22-162)
  Office of the Director, NIH
  

• Notice of Change in Required Registrations for PA-22-176 "PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)"
  (NOT-OD-22-163)
  Office of the Director, NIH
  

• Notice of Change in Required Registrations for PA-22-178 "PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)"
  (NOT-OD-22-164)
  Office of the Director, NIH
  

• Notice of Change in Required Registrations for SBIR and STTR Funding Opportunity Announcements RFA-DA-23-019, RFA-DA-23-020, PAS-22-196, PAS-22-197
  (NOT-OD-22-165)
  Office of the Director, NIH
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for REsearch Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed)
  (NOT-AT-23-001)
  National Center for Complementary and Integrative Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Mechanistic links between diet, lipid metabolism, and tumor growth and progression (R01 Clinical Trial Not Allowed)
  (NOT-CA-22-106)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Mechanistic links between diet, lipid metabolism, and tumor growth and progression (R21 Clinical Trial Not Allowed)
  (NOT-CA-22-107)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: Transformative Brain Non-invasive Imaging Technology Development
  (NOT-EB-22-007)
  National Institute of Biomedical Imaging and Bioengineering
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  

Requests for Proposal

• RESCINDED - Extramural Loan Repayment Program for Clinical Researchers (LRP-CR)
  (NOT-OD-22-148)
  Office of the Director, NIH
  

• RESCINDED - Extramural Loan Repayment Program for Pediatric Research (LRP-PR)
  (NOT-OD-22-149)
  Office of the Director, NIH
  

• RESCINDED - Extramural Loan Repayment Program for Health Disparities Research (LRP-HDR)
  (NOT-OD-22-150)
  Office of the Director, NIH
  

• RESCINDED - Extramural Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds (LRP-IDB)
  (NOT-OD-22-151)
  Office of the Director, NIH
  

• RESCINDED - Extramural Loan Repayment Program for Contraception and Infertility Research (LRP-CIR)
  (NOT-OD-22-152)
  Office of the Director, NIH
  

• RESCINDED - Extramural Loan Repayment Program for Research in Emerging Areas Critical to Human Health (LRP-REACH)
  (NOT-OD-22-153)
  Office of the Director, NIH
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborative HIV/AIDS Research at NIMHD-Funded Research Centers in Minority Institutions (RCMI)
  (NOT-MD-22-021)
  National Institute on Minority Health and Health Disparities
  

• Notice of Special Interest (NOSI): Administrative Supplements to NIMHD Awards for Research on HIV/AIDS in Populations that Experience Health Disparities (Admin Supp Clinical Trial Optional)
  (NOT-MD-22-022)
  National Institute on Minority Health and Health Disparities
  

• Notice of Special Interest (NOSI): Administrative Supplements to Support Research on Preventive Interventions with Populations that Experience Health Disparities (Admin Supp Clinical Trial Optional)
  (NOT-OD-22-159)
  Office of Disease Prevention
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Office of Research on Women's Health
  

Funding Opportunities

• NIDDK Central Repository Non-renewable Sample Access (X01 Clinical Trial Not Allowed)
  (PAR-22-171)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): June 26, 2025
  
  

• NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
  (PAR-22-201)
  National Institute on Drug Abuse
  Application Receipt Date(s): May 06, 2023
  
  

• Structural Biology of Alzheimer's Disease Related Dementias (ADRDs) Proteinopathies (R01 Clinical Trial Not Allowed)
  (PAR-22-208)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): October 07, 2022
  
  

• Molecular Dynamics of HIV (R01 Clinical Trial Not Allowed)
  (RFA-AI-22-050)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Not Applicable
  
  

• Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
  (RFA-AR-23-001)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Heart, Lung, and Blood Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): September 30, 2022
  
  

• Enabling SUD Digital Therapeutics Research to Improve Payor Adoption (R44- Clinical Trial Only)
  (RFA-DA-23-018)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 15, 2022
  
  

• Harnessing Technologies to Support Oral Health Promotion and Management Outside the Dental Setting (UG3/UH3 Clinical Trial Required)
  (RFA-DE-23-009)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): November 21, 2022
  
  

• George M. O'Brien Kidney National Resource Centers (U54 - Clinical Trial Not Allowed)
  (RFA-DK-22-007)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): December 01, 2022
  
  

• National Coordinating Center for the George M. OBrien Kidney National Resource Centers (U24 - Clinical Trial Not Allowed)
  (RFA-DK-22-008)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): December 01, 2022
  
  

• New Approaches for Incorporating Genetic Diversity into Toxicity Testing (R43/R44 Clinical Trial Not Allowed)
  (RFA-ES-22-006)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): November 08, 2022
  
  

• Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01) Clinical Trials Required
  (RFA-FD-23-001)
  Food and Drug Administration
  Application Receipt Date(s): October 22, 2024
  
  

• Commercial Fishing Occupational Safety Research Cooperative Agreement (U01)
  (RFA-OH-22-005)
  National Institute for Occupational Safety and Health
  Application Receipt Date(s): August 30, 2022; January 31, 2023; August 29, 2023; January 30, 2024; August 27, 2024; January 28, 2025; August 26, 2025; January 27, 2026; August 25, 2026; January 26, 2027 All applications are due by 5:00 PM U.S. Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Commercial Fishing Occupational Safety Training Project Grants (T03)
  (RFA-OH-22-006)
  National Institute for Occupational Safety and Health
  Application Receipt Date(s): January 30, 2028
  
  

• Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
  (RFA-TR-22-030)
  National Center for Advancing Translational Sciences
  National Institute of Mental Health
  Application Receipt Date(s): July 15, 2024